Editas Medicine, Inc

(NASDAQ:EDIT)

Latest On Editas Medicine, Inc (EDIT):

Date/Time Type Description Signal Details
2023-05-18 19:53 ESTNewsEditas Medicine strengthens board of directors with appointment of new chair and new directorN/A
2023-05-17 02:54 ESTNewsEditas Medicine, Inc. (EDIT) RBC Capital Markets Global Healthcare Conference 2023 TranscriptN/A
2023-05-17 02:54 ESTNewsEditas Medicine appoints Erick Lucera as CFO, Michelle Robertson steps downN/A
2023-05-14 04:40 ESTNewsEditas Medicine, Inc. (EDIT) Bank of America Global Healthcare Conference Call TranscriptN/A
2023-05-06 02:18 ESTNewsEditas Medicine, Inc. (EDIT) Q1 2023 Earnings Call TranscriptN/A
2023-05-06 02:18 ESTNewsEditas Medicine: Pioneering Gene-Editing Solutions For Inherited Blood Disorders And BeyondN/A
2023-05-05 13:29 ESTNewsEditas Medicine GAAP EPS of -$0.71 beats by $0.08N/A
2023-05-05 00:35 ESTNewsEditas Medicine Q1 2023 Earnings PreviewN/A
2023-04-27 18:11 ESTNewsEditas sickle cell candidate granted FDA Orphan Drug designationN/A
2023-04-13 20:11 ESTNewsHot Stocks: PGR drops on earnings; CNSL rises on buyout offer; MRK higher on analyst upgrade; EDIT gains; HOG slidesN/A
2023-04-13 20:11 ESTNewsGene editing stocks rally as Wall Street turns bullishN/A
2023-02-24 03:35 ESTNewsEditas: The Potential Of Gene Editing Technology And The Risks Of A Lackluster PipelineN/A
2023-02-23 01:21 ESTNewsEditas rises on Q4 revenue beat, gene-editing therapy data for sickle cell disease by mid-yearN/A
2023-02-23 01:21 ESTNewsEditas Medicine, Inc. (EDIT) Q4 2022 Earnings Call TranscriptN/A
2023-02-22 12:28 ESTNewsEditas Medicine GAAP EPS of -$0.88 misses by $0.08, revenue of $6.54M beats by $2.78MN/A
2023-02-21 23:52 ESTNewsEditas Medicine Q4 2022 Earnings PreviewN/A
2023-02-01 16:15 ESTNewsEditas, Beam win bullish views as Cantor launches gene editing coverageN/A
2023-01-19 18:17 ESTNewsEditas to sell natural killer cell programs to ShorelineN/A
2023-01-11 22:12 ESTNewsEditas Medicine, Inc. (EDIT) Presents at 41st Annual J.P. Morgan Healthcare Conference (Transcript)N/A
2023-01-09 15:48 ESTNewsEditas cuts 20% staff in portfolio overhaulN/A
2022-12-06 18:46 ESTNewsEditas adds 12% after initial data for sickle cell disease candidateN/A
2022-12-06 18:46 ESTNewsEditas Medicine, Inc. (EDIT) EDIT-301 Clinical Update 2022 - (Transcript)N/A
2022-12-06 18:45 ESTNewsEDIT-301 Clinical UpdateN/A
2022-12-06 18:45 ESTNewsEditas Medicine: 3 Positives To Cling To In 2023 (And Why They May Not Be So Positive)N/A
2022-11-18 13:41 ESTNewsEditas Medicine dropped to neutral at Credit Suisse following EDIT-101 trial dataN/A
2022-11-17 20:34 ESTNewsEditas pausing enrollment of blindness drug trial to find partner; shares down 15%N/A
2022-11-04 19:09 ESTNewsEditas Medicine: Q3 Update And 2 Clinical Catalysts To WatchN/A
2022-11-02 16:42 ESTNewsEditas Medicine GAAP EPS of -$0.81 beats by $0.07N/A
2022-11-02 16:41 ESTNewsEditas Medicine, Inc. (EDIT) Q3 2022 Earnings Call TranscriptN/A
2022-11-02 16:41 ESTNewsEditas Medicine rises 7% on Q3 earnings beatN/A
2022-11-02 01:05 ESTNewsEditas Medicine Q3 2022 Earnings PreviewN/A
2022-10-18 18:19 ESTNewsEditas Medicine gains on report of potential sale of pre-clinical cancer pipelineN/A
2022-09-30 01:23 ESTNewsEditas Medicine started at neutral at BofA due to competition in gene editing programsN/A
2022-09-12 17:06 ESTNewsEditas Medicine, Inc. (EDIT) Management Presents at Morgan Stanley 20th Annual Global Healthcare Conference Call TranscriptN/A
2022-09-08 10:35 ESTNewsEditas Medicine, Inc. (EDIT) Presents at 2022 Wells Fargo Healthcare Conference (Transcript)N/A
2022-08-25 11:55 ESTNewsEditas Medicine: Management Upbeat After Lifting Of Clinical HoldN/A
2022-08-24 03:30 ESTNewsEditas: End Of Year Data Readouts For SCD And Rare Eye Disease StudiesN/A
2022-08-04 10:30 ESTNewsEditas Medicine, Inc. (EDIT) CEO Gilmore O'Neill on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-03 20:10 ESTNewsEditas Medicine GAAP EPS of -$0.78 beats by $0.06, revenue of $6.36M beats by $2.07MN/A
2022-08-03 20:10 ESTNewsEditas Medicine up 13% following Q2 2022 top and bottom line beats as net loss narrowsN/A
2022-08-03 20:09 ESTNewsGene editing companies benefitting from Roche deal with CAR-T player Poseida TherapeuticsN/A
2022-08-02 14:41 ESTNewsEditas Medicine Q2 2022 Earnings PreviewN/A
2022-07-18 11:17 ESTNewsBaisong Mei joins Editas Medicine as Chief Medical OfficerN/A
2022-06-07 11:20 ESTNewsEditas in licensing deal with Immatics for cancer therapiesN/A
2022-06-06 20:01 ESTNewsEditas: Tackling Rare Eye Disease With Use Of Crispr TechnologyN/A
2022-05-13 12:13 ESTNewsEditas Medicine granted Orphan Drug Designation for beta thalassemia candidateN/A
2022-05-05 02:50 ESTNewsEditas Medicine GAAP EPS of -$0.74 beats by $0.07, revenue of $6.77M beats by $2.92MN/A
2022-05-05 02:50 ESTNewsEditas Medicine, Inc. (EDIT) CEO Jim Mullen on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 06:05 ESTNewsEditas Medicine Q1 2022 Earnings PreviewN/A
2022-04-26 11:41 ESTNewsEditas gets FDA rare pediatric disease status for gene-edited drug EDIT-301 for beta thalassemiaN/A

About Editas Medicine, Inc (EDIT):

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary genome editing platform based on CRISPR technology to target genetically addressable diseases and therapeutic areas. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis type 10, a genetic form of vision loss that leads to blindness in childhood. It also develops EDIT-102 for the treatment of Usher Syndrome 2A, which is a form of retinitis pigmentosa that also includes hearing loss; autosomal dominant retinitis pigmentosa 4, a progressive form of retinal degeneration; and EDIT-301 to treat sickle cell disease and beta-thalassemia. In addition, the company is developing gene-edited Natural Killer cell medicines to treat solid tumors; alpha-beta T cells for multiple cancers; and gamma delta T cell therapies to treat cancer, as well as has a early discovery program to develop a therapy to treat a neurological disease. It has a research collaboration with Juno Therapeutics, Inc. to develop engineered T cells for cancer; strategic alliance and option agreement with Allergan Pharmaceuticals International Limited to discover, develop, and commercialize new gene editing medicines for a range of ocular disorders; and research collaboration with Asklepios BioPharmaceutical, Inc. to develop a therapy to treat a neurological disease, as well as research collaboration with AskBio and collaboration with m BlueRock Therapeutics LP. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.

EDIT Quotes by TradingView

See Advanced Chart

General

  • Name Editas Medicine, Inc
  • Symbol EDIT
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 235
  • Fiscal Year EndDecember
  • IPO Date2016-02-03
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.editasmedicine.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 26.85
  • Price/Book (Most Recent Quarter) 6.25
  • Enterprise Value Revenue 25.23
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$3.34
  • Next Year EPS Estimate -$3.49
  • Next Quarter EPS Estimate -$0.78
  • Profit Margin -128%
  • Operating Margin -149%
  • Return on Assets -16%
  • Return on Equity -35%
  • Revenue 90.73 million
  • Earnings Per Share -$2.14
  • Revenue Per Share $1.55
  • Gross Profit -67264000
  • Quarterly Earnings Growth -7%
View More

Highlights

  • Market Capitalization 2.91 billion
  • EBITDA -106383000
  • PE Ratio -1.59
  • Analyst Target Price $52.83
  • Book Value Per Share $6.29
View More

Share Statistics

  • Shares Outstanding 67.36 million
  • Shares Float 66.37 million
  • % Held by Insiders 137%
  • % Held by Institutions 82.21%
  • Shares Short 11.31 million
  • Shares Short Prior Month 9.84 million
  • Short Ratio 4.22
  • Short % of Float 17%
  • Short % of Shares Outstanding 17%
View More

Technicals

  • Beta 2.08
  • 52 Week High $99.95
  • 52 Week Low $18.2
  • 50 Day Moving Average 52.94
  • 200 Day Moving Average 46.49
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Editas Medicine, Inc (EDIT) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Editas Medicine, Inc (EDIT) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A-$1.00-$0.88-13.56%
2020-09-302020-11-05$N/A$0.12-$0.63119.14%
2020-06-302020-08-06$N/A-$0.43-$0.8247.37%
2020-03-312020-05-07$N/A-$0.69-$0.8114.81%
2019-12-312020-02-26$12.28 million-$0.74$0.06-1380.28%
2019-09-302019-11-12$3.85 million-$0.66-$0.739.3%
2019-06-302019-08-06$2.33 million-$0.69-$0.62-10.79%
2019-03-312019-05-07$2.07 million-$0.60-$0.645.78%
2018-12-312019-02-28$6.12 million-$0.52-$0.555.45%
2018-09-302018-11-07$14.52 million-$0.32-$0.8160.7%
2018-06-302018-08-06$7.37 million-$0.82-$0.66-25.1%
2018-03-312018-05-03$3.93 million-$0.67-$0.8016.47%
2017-12-312018-03-06$3.67 million-$0.84-$0.67-25.88%
2017-09-302017-11-07$6.28 million-$0.64-$0.63-1.81%
2017-06-302017-08-09$3.1 million-$0.65-$0.57-13.38%
2017-03-312017-05-15$682000-$0.85-$0.77-11.05%
2016-12-312017-03-03$898000-$1.10-$0.65-68.69%
2016-09-302016-11-07$962000-$0.59-$0.648%
2016-06-302016-08-09$3.39 million-$0.54-$0.562.76%
2016-03-312016-05-13$805000-$0.80-$0.32-150.94%
2015-12-312016-03-30$792000-$4.05-$8.5652.69%

Editas Medicine, Inc (EDIT) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Editas Medicine, Inc (EDIT) Chart:

Editas Medicine, Inc (EDIT) News:

Below you will find a list of latest news for Editas Medicine, Inc (EDIT) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Editas Medicine, Inc (EDIT) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-09-190.52.5CALL0 30TRUE00
2025-09-1910CALL0 0419.6TRUE00
2025-09-191.50CALL0 0223.97TRUE00
2025-09-1920.55CALL0 41182.25TRUE00
2025-09-192.50.5CALL90 718113.05TRUE0.10.25
2025-09-1950.03CALL22 1535131.66FALSE-0.01-0.25
2025-09-197.50CALL0 0189.41FALSE00
2025-09-190.50PUT0 0391.2FALSE00
2025-09-1910PUT0 0239.08FALSE00
2025-09-191.50.04PUT0 5486.13FALSE00
2025-09-1920.05PUT0 7193.25FALSE00
2025-09-192.50.13PUT4 51589.01FALSE-0.04-0.24
2025-09-1952PUT0 6135.88TRUE00
2025-09-197.54.5PUT0 10TRUE00
2025-10-170.50CALL0 01030.6TRUE00
2025-10-1710CALL0 0475TRUE00
2025-10-171.51.5CALL0 1337.66TRUE00
2025-10-1720CALL0 073.1TRUE00
2025-10-172.50.63CALL2 176112.03TRUE0.630
2025-10-1750.06CALL28 19107.68FALSE-0.04-0.4
2025-10-177.50CALL0 0233.03FALSE00
2025-10-170.50PUT0 0274.62FALSE00
2025-10-1710PUT0 0514.84FALSE00
2025-10-171.50PUT0 0341.77FALSE00
2025-10-1720PUT0 0238.23FALSE00
2025-10-172.50.3PUT0 4101.82FALSE00
2025-10-1750PUT0 0112.73TRUE00
2025-10-177.50PUT0 00TRUE00
2025-11-210.50CALL0 147410.85TRUE00
2025-11-2112.1CALL0 487146.26TRUE00
2025-11-211.52CALL0 105106.52TRUE00
2025-11-2121.09CALL1 450128.2TRUE0.130.14
2025-11-212.50.75CALL2840 5855111.03TRUE0.750
2025-11-2150.19CALL0 861103.09FALSE00
2025-11-217.50.05CALL0 165144.31FALSE00
2025-11-210.50PUT0 0469.48FALSE00
2025-11-2110PUT0 1205.02FALSE00
2025-11-211.50.2PUT0 28136.27FALSE00
2025-11-2120.21PUT0 161116.4FALSE00
2025-11-212.50.46PUT0 202110.98FALSE00
2025-11-2152.26PUT0 109105.99TRUE00
2025-11-217.55.1PUT0 24134.13TRUE00
2026-01-160.52.4CALL0 120239.33TRUE00
2026-01-1611.89CALL280 1846136.12TRUE1.890
2026-01-161.51.51CALL36 516290.38TRUE1.510
2026-01-1621.21CALL15 166795.91TRUE0.190.19
2026-01-162.50.9CALL410 4810110.23TRUE0.050.06
2026-01-1650.27CALL355 8979106.05FALSE-0.05-0.16
2026-01-167.50.15CALL22 3885118.41FALSE0.040.36
2026-01-16100.1CALL0 2930119.33FALSE00
2026-01-1612.50.08CALL0 748133.61FALSE00
2026-01-16150.07CALL0 721134.91FALSE00
2026-01-1617.50.06CALL0 332143.79FALSE00
2026-01-16200.01CALL0 1227151.31FALSE00
2026-01-160.50PUT0 4503.78FALSE00
2026-01-1610.04PUT0 208122.51FALSE00
2026-01-161.50.15PUT0 349107.77FALSE00
2026-01-1620.25PUT0 39281.56FALSE00
2026-01-162.50.46PUT1 28293.94FALSE-0.06-0.12
2026-01-1652.33PUT0 183100.48TRUE00
2026-01-167.54.26PUT0 172110.81TRUE00
2026-01-16107.75PUT0 9134.81TRUE00
2026-01-1612.50PUT0 00TRUE00
2026-01-16150PUT0 0238.01TRUE00
2026-01-1617.50PUT0 0216.81TRUE00
2026-01-162016.9PUT0 20TRUE00
2026-02-200.52.6CALL0 1325.97TRUE00
2026-02-2011.28CALL0 9113.14TRUE00
2026-02-201.51.05CALL0 10109.73TRUE00
2026-02-2021CALL0 33594.79TRUE00
2026-02-202.50.95CALL11 265105.88TRUE0.10.12
2026-02-2050.35CALL23 1362106.17FALSE0.030.09
2026-02-207.50.15CALL3 228106.13FALSE0.020.15
2026-02-200.50PUT0 0453.75FALSE00
2026-02-2010PUT0 0238.67FALSE00
2026-02-201.50.15PUT0 12110.9FALSE00
2026-02-2020.33PUT0 3897.28FALSE00
2026-02-202.50.51PUT0 5965.32FALSE00
2026-02-2052.99PUT0 398.98TRUE00
2026-02-207.54.8PUT0 4101.59TRUE00

Latest EDIT Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST6$9.99
Jun 13, 2022 7:59 PM EST1$9.99
Jun 13, 2022 7:59 PM EST1$9.99
Jun 13, 2022 7:59 PM EST4$9.99
Jun 13, 2022 7:59 PM EST7$9.99

Editas Medicine, Inc (EDIT) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000110465920076658/0001104659-20-076658-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000009375119000066/0000093751-19-000066-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000021545719004070/0000215457-19-004070-index.htm
2018-08-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000031506618002155/0000315066-18-002155-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000083423720005329/0000834237-20-005329-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000093247119004821/0000932471-19-004821-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000093247119004830/0000932471-19-004830-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000095010320002668/0000950103-20-002668-index.htm
2019-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1650664/000104746919002633/0001047469-19-002633-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1650664/000104746920002641/0001047469-20-002641-index.htm
2020-05-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1650664/000104746920003096/0001047469-20-003096-index.htm
2020-06-23S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1650664/000104746920003806/0001047469-20-003806-index.htm
2020-06-25424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1650664/000104746920003852/0001047469-20-003852-index.htm
2019-01-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000110465919002543/0001104659-19-002543-index.htm
2019-04-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1650664/000110465919024075/0001104659-19-024075-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000110465920018014/0001104659-20-018014-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000110465920021157/0001104659-20-021157-index.htm
2020-04-28DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1650664/000110465920052376/0001104659-20-052376-index.htm
2020-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000110465920076658/0001104659-20-076658-index.htm
2020-10-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000110465920113794/0001104659-20-113794-index.htm
2019-10-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000114036119018224/0001140361-19-018224-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000114036120002957/0001140361-20-002957-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000114420419007778/0001144204-19-007778-index.htm
2018-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/0001179110-18-008837-index.htm
2018-07-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018009472/0001179110-18-009472-index.htm
2018-07-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm
2018-08-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018010246/0001179110-18-010246-index.htm
2018-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/0001179110-18-010732-index.htm
2018-08-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018010766/0001179110-18-010766-index.htm
2018-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018011143/0001179110-18-011143-index.htm
2018-09-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018011549/0001179110-18-011549-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018011848/0001179110-18-011848-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018011999/0001179110-18-011999-index.htm
2018-10-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018012272/0001179110-18-012272-index.htm
2018-10-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018012390/0001179110-18-012390-index.htm
2018-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018012584/0001179110-18-012584-index.htm
2018-11-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/0001179110-18-013070-index.htm
2018-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018013245/0001179110-18-013245-index.htm
2018-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018013511/0001179110-18-013511-index.htm
2018-12-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018013607/0001179110-18-013607-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018013609/0001179110-18-013609-index.htm
2018-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018014142/0001179110-18-014142-index.htm
2019-01-084/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019000574/0001179110-19-000574-index.htm
2019-01-084/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019000576/0001179110-19-000576-index.htm
2019-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019000578/0001179110-19-000578-index.htm
2019-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019000653/0001179110-19-000653-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019001235/0001179110-19-001235-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019001237/0001179110-19-001237-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019001239/0001179110-19-001239-index.htm
2019-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019001436/0001179110-19-001436-index.htm
2019-02-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019001511/0001179110-19-001511-index.htm
2019-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019001519/0001179110-19-001519-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019001682/0001179110-19-001682-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019001684/0001179110-19-001684-index.htm
2019-02-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019002313/0001179110-19-002313-index.htm
2019-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019003510/0001179110-19-003510-index.htm
2019-03-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019003602/0001179110-19-003602-index.htm
2019-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019004095/0001179110-19-004095-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019007669/0001179110-19-007669-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019007675/0001179110-19-007675-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019007680/0001179110-19-007680-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019007682/0001179110-19-007682-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019007685/0001179110-19-007685-index.htm
2019-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019009249/0001179110-19-009249-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019009744/0001179110-19-009744-index.htm
2019-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019010316/0001179110-19-010316-index.htm
2019-10-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019011287/0001179110-19-011287-index.htm
2019-10-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019011289/0001179110-19-011289-index.htm
2020-01-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020000466/0001179110-20-000466-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020000468/0001179110-20-000468-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020001026/0001179110-20-001026-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020001362/0001179110-20-001362-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020001370/0001179110-20-001370-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020005605/0001179110-20-005605-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020007263/0001179110-20-007263-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020007265/0001179110-20-007265-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020007273/0001179110-20-007273-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020007277/0001179110-20-007277-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020007280/0001179110-20-007280-index.htm
2020-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020008367/0001179110-20-008367-index.htm
2020-08-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020008833/0001179110-20-008833-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020009170/0001179110-20-009170-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020009219/0001179110-20-009219-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020010507/0001179110-20-010507-index.htm
2018-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000118248918000336/0001182489-18-000336-index.htm
2019-10-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000121465919006312/0001214659-19-006312-index.htm
2018-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837018006448/0001558370-18-006448-index.htm
2018-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1650664/000155837018006577/0001558370-18-006577-index.htm
2018-10-2310-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1650664/000155837018007793/0001558370-18-007793-index.htm
2018-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837018008795/0001558370-18-008795-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1650664/000155837018008907/0001558370-18-008907-index.htm
2018-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837018009647/0001558370-18-009647-index.htm
2018-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837018009781/0001558370-18-009781-index.htm
2019-01-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837019000186/0001558370-19-000186-index.htm
2019-02-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837019000455/0001558370-19-000455-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837019001317/0001558370-19-001317-index.htm
2019-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1650664/000155837019001364/0001558370-19-001364-index.htm
2019-03-14S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1650664/000155837019002001/0001558370-19-002001-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837019004256/0001558370-19-004256-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1650664/000155837019004444/0001558370-19-004444-index.htm
2019-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837019005722/0001558370-19-005722-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837019007255/0001558370-19-007255-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1650664/000155837019007470/0001558370-19-007470-index.htm
2019-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837019008737/0001558370-19-008737-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837019010674/0001558370-19-010674-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1650664/000155837019010798/0001558370-19-010798-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837020000118/0001558370-20-000118-index.htm
2020-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837020001469/0001558370-20-001469-index.htm
2020-02-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1650664/000155837020001476/0001558370-20-001476-index.htm
2020-02-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1650664/000155837020001479/0001558370-20-001479-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837020005306/0001558370-20-005306-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837020005548/0001558370-20-005548-index.htm
2020-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1650664/000155837020005883/0001558370-20-005883-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837020006724/0001558370-20-006724-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837020007536/0001558370-20-007536-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837020009648/0001558370-20-009648-index.htm
2020-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1650664/000155837020009821/0001558370-20-009821-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837020012865/0001558370-20-012865-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1650664/000155837020013022/0001558370-20-013022-index.htm
2018-10-18CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1650664/999999999718008672/9999999997-18-008672-index.htm
2018-10-18CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1650664/999999999718008675/9999999997-18-008675-index.htm
2018-10-18CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1650664/999999999718008677/9999999997-18-008677-index.htm
2018-10-25CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1650664/999999999718008797/9999999997-18-008797-index.htm
2019-09-23SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1650664/999999999719007052/9999999997-19-007052-index.htm
2019-09-26SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1650664/999999999719007131/9999999997-19-007131-index.htm
2019-10-24CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1650664/999999999719007341/9999999997-19-007341-index.htm
2019-12-26CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1650664/999999999719007956/9999999997-19-007956-index.htm
2020-04-27CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1650664/999999999720002192/9999999997-20-002192-index.htm

Editas Medicine, Inc (EDIT) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Editas Medicine, Inc (EDIT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 137%
Institutional Ownership: 8221%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-08-31Andrew A. F. HackChief Financial OfficerSell10,000.0032.23322,300.000.00https://www.sec.gov/Archives/edgar/data/1650664/000118248918000336/0001182489-18-000336-index.htm
2018-09-28Andrew A. F. HackChief Financial OfficerSell8,000.0032.08256,640.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018011848/0001179110-18-011848-index.htm
2018-10-26Andrew A. F. HackChief Financial OfficerSell6,000.0025.70154,200.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018012390/0001179110-18-012390-index.htm
2018-11-23Andrew A. F. HackChief Financial OfficerSell100.0028.612,861.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018013245/0001179110-18-013245-index.htm
2019-01-04Andrew A. F. HackChief Financial OfficerSell7,000.0022.48157,360.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019000578/0001179110-19-000578-index.htm
2019-02-04Andrew A. F. HackChief Financial OfficerSell6,895.0021.39147,484.050.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019001436/0001179110-19-001436-index.htm
2018-06-18Vickesh MyerChief Technology OfficerSell4,300.0037.75162,325.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/0001179110-18-008837-index.htm
2018-06-18Vickesh MyerChief Technology OfficerSell2,700.0038.71104,517.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/0001179110-18-008837-index.htm
2018-06-19Vickesh MyerChief Technology OfficerSell7,000.0038.39268,730.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/0001179110-18-008837-index.htm
2018-07-17Vickesh MyerChief Technology OfficerSell3,000.0034.66103,980.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm
2018-07-17Vickesh MyerChief Technology OfficerSell4,000.0036.50146,000.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm
2018-07-18Vickesh MyerChief Technology OfficerSell6,150.0035.46218,079.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm
2018-07-18Vickesh MyerChief Technology OfficerSell850.0036.2530,812.500.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm
2018-08-17Vickesh MyerChief Technology OfficerSell3,000.0029.6588,950.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/0001179110-18-010732-index.htm
2018-08-20Vickesh MyerChief Technology OfficerSell3,600.0029.81107,316.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/0001179110-18-010732-index.htm
2018-08-20Vickesh MyerChief Technology OfficerSell400.0030.4112,164.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/0001179110-18-010732-index.htm
2018-09-17Vickesh MyerChief Technology OfficerSell3,000.0032.3396,990.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018011549/0001179110-18-011549-index.htm
2018-09-18Vickesh MyerChief Technology OfficerSell4,000.0032.19128,760.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018011549/0001179110-18-011549-index.htm
2018-10-17Vickesh MyerChief Technology OfficerSell3,000.0028.8786,610.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018012272/0001179110-18-012272-index.htm
2018-10-18Vickesh MyerChief Technology OfficerSell4,000.0029.44117,760.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018012272/0001179110-18-012272-index.htm
2018-11-19Vickesh MyerChief Technology OfficerSell2,700.0028.1275,924.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/0001179110-18-013070-index.htm
2018-11-19Vickesh MyerChief Technology OfficerSell300.0028.858,655.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/0001179110-18-013070-index.htm
2018-11-20Vickesh MyerChief Technology OfficerSell4,000.0026.50106,000.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/0001179110-18-013070-index.htm
2018-12-17Vickesh MyerChief Technology OfficerSell700.0028.3419,838.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018014142/0001179110-18-014142-index.htm
2018-12-18Vickesh MyerChief Technology OfficerSell4,000.0027.41109,640.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018014142/0001179110-18-014142-index.htm
2019-01-17Vickesh MyerChief Technology OfficerSell3,000.0026.1878,540.000.00https://www.sec.gov/Archives/edgar/data/1650664/000110465919002543/0001104659-19-002543-index.htm
2019-01-18Vickesh MyerChief Technology OfficerSell4,000.0026.50106,000.000.00https://www.sec.gov/Archives/edgar/data/1650664/000110465919002543/0001104659-19-002543-index.htm
2019-02-20Vickesh MyerChief Technology OfficerSell3,000.0020.4261,260.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019002313/0001179110-19-002313-index.htm
2019-03-18Vickesh MyerChief Technology OfficerSell3,000.0024.5073,500.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019004095/0001179110-19-004095-index.htm
2018-11-23Andrew A. F. HackChief Financial OfficerSell5,184.0028.14145,877.76100.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018013245/0001179110-18-013245-index.htm
2018-08-31Andrew A. F. HackChief Financial OfficerBuy10,000.006.4864,800.0010,000.00https://www.sec.gov/Archives/edgar/data/1650664/000118248918000336/0001182489-18-000336-index.htm
2019-08-19Cynthia CollinsCEOSell5,193.0025.83134,135.1911,373.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019009744/0001179110-19-009744-index.htm
2019-01-08Katrine BosleyPresident and CEOSell12,000.0025.27303,240.001,204,966.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019000653/0001179110-19-000653-index.htm
2018-12-03Katrine BosleyPresident and CEOSell100.0032.393,239.001,216,966.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018013511/0001179110-18-013511-index.htm
2018-12-03Katrine BosleyPresident and CEOSell11,900.0031.92379,848.001,217,066.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018013511/0001179110-18-013511-index.htm
2018-11-01Katrine BosleyPresident and CEOSell8,600.0027.21234,006.001,228,966.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018012584/0001179110-18-012584-index.htm
2018-11-01Katrine BosleyPresident and CEOSell3,400.0026.0388,502.001,237,566.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018012584/0001179110-18-012584-index.htm
2018-10-01Katrine BosleyPresident and CEOSell5,766.0031.44181,283.041,240,966.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018011999/0001179110-18-011999-index.htm
2018-10-01Katrine BosleyPresident and CEOSell6,234.0030.64191,009.761,246,732.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018011999/0001179110-18-011999-index.htm
2018-09-04Katrine BosleyPresident and CEOSell1,213.0033.0740,113.911,252,966.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018011143/0001179110-18-011143-index.htm
2018-09-04Katrine BosleyPresident and CEOSell10,787.0032.27348,096.491,254,179.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018011143/0001179110-18-011143-index.htm
2018-08-20Katrine BosleyPresident and CEOSell5,433.0030.43165,326.191,264,966.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018010766/0001179110-18-010766-index.htm
2018-08-20Katrine BosleyPresident and CEOSell6,567.0029.95196,681.651,270,399.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018010766/0001179110-18-010766-index.htm
2018-08-01Katrine BosleyPresident and CEOSell2,100.0030.1263,252.001,276,966.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018010246/0001179110-18-010246-index.htm
2018-08-01Katrine BosleyPresident and CEOSell6,233.0029.36183,000.881,279,066.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018010246/0001179110-18-010246-index.htm
2018-07-02Katrine BosleyPresident and CEOSell5,333.0036.46194,441.181,285,299.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018009472/0001179110-18-009472-index.htm
2018-07-02Katrine BosleyPresident and CEOSell3,000.0036.00108,000.001,290,632.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018009472/0001179110-18-009472-index.htm
2019-08-06Cynthia CollinsCEOBuy8,283.0016,566.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019009249/0001179110-19-009249-index.htm
2019-08-19Cynthia CollinsCEOBuy8,283.0016,566.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019009744/0001179110-19-009744-index.htm
2019-03-05Jessica HopfieldDirectorBuy10,200.0023.94244,188.0016,900.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019003510/0001179110-19-003510-index.htm
2020-01-09MICHELLE ROBERTSONChief Financial OfficerBuy20,000.0020,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020000468/0001179110-20-000468-index.htm
2020-02-03Charles AlbrightChief Scientific OfficerSell5,549.0026.54147,287.6620,553.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020001026/0001179110-20-001026-index.htm
2019-10-28Judith R AbramsChief Medical OfficerBuy25,000.0025,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019011289/0001179110-19-011289-index.htm
2020-10-15Charles AlbrightEVP/Chief Scientific OfficerSell3,000.0031.3994,170.0025,135.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020010507/0001179110-20-010507-index.htm
2020-01-31Charles AlbrightChief Scientific OfficerBuy17,977.0026,102.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020001026/0001179110-20-001026-index.htm
2018-06-18Vickesh MyerChief Technology OfficerBuy2,700.000.651,755.002,700.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/0001179110-18-008837-index.htm
2018-11-19Vickesh MyerChief Technology OfficerBuy2,700.000.651,755.002,700.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/0001179110-18-013070-index.htm
2020-08-07Charles AlbrightEVP/Chief Scientific OfficerSell238.0034.998,327.6228,135.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020008833/0001179110-20-008833-index.htm
2020-08-17Charles AlbrightEVP/Chief Scientific OfficerSell10,000.0035.29352,900.0028,135.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020009170/0001179110-20-009170-index.htm
2020-07-15Charles AlbrightEVP/Chief Scientific OfficerSell3,000.0032.2296,660.0028,373.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020008367/0001179110-20-008367-index.htm
2020-08-06Charles AlbrightEVP/Chief Scientific OfficerSell10,000.0037.47374,700.0028,373.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020008833/0001179110-20-008833-index.htm
2018-11-19Vickesh MyerChief Technology OfficerBuy300.000.65195.00300.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/0001179110-18-013070-index.htm
2018-07-17Vickesh MyerChief Technology OfficerBuy3,000.000.651,950.003,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm
2018-08-17Vickesh MyerChief Technology OfficerBuy3,000.000.651,950.003,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/0001179110-18-010732-index.htm
2018-09-17Vickesh MyerChief Technology OfficerBuy3,000.000.651,950.003,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018011549/0001179110-18-011549-index.htm
2018-10-17Vickesh MyerChief Technology OfficerBuy3,000.000.651,950.003,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018012272/0001179110-18-012272-index.htm
2018-12-17Vickesh MyerChief Technology OfficerBuy3,000.000.651,950.003,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018014142/0001179110-18-014142-index.htm
2019-01-17Vickesh MyerChief Technology OfficerBuy3,000.000.651,950.003,000.00https://www.sec.gov/Archives/edgar/data/1650664/000110465919002543/0001104659-19-002543-index.htm
2019-02-20Vickesh MyerChief Technology OfficerBuy3,000.000.651,950.003,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019002313/0001179110-19-002313-index.htm
2019-03-18Vickesh MyerChief Technology OfficerBuy3,000.000.651,950.003,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019004095/0001179110-19-004095-index.htm
2020-05-06Charles AlbrightEVP/Chief Scientific OfficerSell151.0025.283,817.2831,373.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020005605/0001179110-20-005605-index.htm
2019-09-11Cynthia CollinsCEOBuy20,000.0031,373.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019010316/0001179110-19-010316-index.htm
2020-02-07Charles AlbrightChief Scientific OfficerSell622.0026.9516,762.9031,524.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020001370/0001179110-20-001370-index.htm
2020-02-06Charles AlbrightChief Scientific OfficerBuy11,593.0032,146.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020001370/0001179110-20-001370-index.htm
2018-08-20Vickesh MyerChief Technology OfficerBuy3,600.0011.2140,356.003,600.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/0001179110-18-010732-index.htm
2020-08-17Charles AlbrightEVP/Chief Scientific OfficerBuy10,000.0016.51165,100.0038,135.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020009170/0001179110-20-009170-index.htm
2020-08-06Charles AlbrightEVP/Chief Scientific OfficerBuy10,000.0016.51165,100.0038,373.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020008833/0001179110-20-008833-index.htm
2018-08-20Vickesh MyerChief Technology OfficerBuy400.0011.214,484.00400.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/0001179110-18-010732-index.htm
2018-07-17Vickesh MyerChief Technology OfficerBuy4,000.000.652,600.004,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm
2018-09-18Vickesh MyerChief Technology OfficerBuy4,000.0011.2144,840.004,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018011549/0001179110-18-011549-index.htm
2018-10-18Vickesh MyerChief Technology OfficerBuy4,000.0011.2144,840.004,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018012272/0001179110-18-012272-index.htm
2018-11-20Vickesh MyerChief Technology OfficerBuy4,000.0011.2144,840.004,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/0001179110-18-013070-index.htm
2018-12-18Vickesh MyerChief Technology OfficerBuy4,000.0011.2144,840.004,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018014142/0001179110-18-014142-index.htm
2019-01-18Vickesh MyerChief Technology OfficerBuy4,000.0011.2144,840.004,000.00https://www.sec.gov/Archives/edgar/data/1650664/000110465919002543/0001104659-19-002543-index.htm
2018-06-18Vickesh MyerChief Technology OfficerBuy4,300.000.652,795.004,300.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/0001179110-18-008837-index.htm
2020-08-20Cynthia CollinsCEOSell1,976.0036.6672,440.1645,022.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020009219/0001179110-20-009219-index.htm
2020-02-06Cynthia CollinsCEOBuy15,625.0046,998.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020001362/0001179110-20-001362-index.htm
2018-11-23Andrew A. F. HackChief Financial OfficerBuy5,284.006.4834,240.325,284.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018013245/0001179110-18-013245-index.htm
2018-10-26Andrew A. F. HackChief Financial OfficerBuy6,000.006.4838,880.006,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018012390/0001179110-18-012390-index.htm
2018-07-18Vickesh MyerChief Technology OfficerBuy6,150.0011.2168,941.506,150.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm
2019-02-04Andrew A. F. HackChief Financial OfficerBuy6,895.006.4844,679.606,895.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019001436/0001179110-19-001436-index.htm
2018-12-17Vickesh MyerChief Technology OfficerSell2,300.0027.7563,825.00700.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018014142/0001179110-18-014142-index.htm
2019-01-04Andrew A. F. HackChief Financial OfficerBuy7,000.006.4845,360.007,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019000578/0001179110-19-000578-index.htm
2018-06-19Vickesh MyerChief Technology OfficerBuy7,000.0011.2178,470.007,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/0001179110-18-008837-index.htm
2018-09-28Andrew A. F. HackChief Financial OfficerBuy8,000.006.4851,840.008,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018011848/0001179110-18-011848-index.htm
2018-07-18Vickesh MyerChief Technology OfficerBuy850.0011.219,528.50850.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm